Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 562
Selected: 0
NCT IDTitle
NCT07083375A Phase II Study of QL1706 With Anti-angiogenesis Therapy and Chemotherapy in Extensive-stage Small Cell Lung Cancer.
NCT07239245Study to Evaluate the Efficacy and Safety of Neo-Adjuvant TACE and Atezolizumab Plus Bevacizumab Therapy for High-Risk Recurrent Hepatocellular Carcinamo
NCT07286695Fruquintinib Combined With Trifluridine/Tipiracil Versus Bevacizumab Combined With Trifluridine/Tipiracil for Advanced Metastatic Colorectal Cancer
NCT07034742Exploratory Study on the Application of Molecular Residual Disease (MRD) in Postoperative Treatment of Gastric Cancer
NCT01918241Saftey and Efficacy of Pegfilgrastim in Preventing Chrmotherapy-induced Neutropenia
NCT07480837Dynamic Monitoring of Plasma ctDNA for Prognostic Assessment in Patients With B-Cell Non-Hodgkin Lymphoma
NCT04466137Phase 3 Study to Evaluate the Safety and Efficacy of YPEG-rhG-CSF in Malignancies Receiving Chemotherapy
NCT01745107Efficacy of Intensity Modulated Radiation Therapy After Surgery in Early Stage of Esophageal Carcinoma;
NCT03791125Phase I Single-dose Escalation Clinical Trial of Salvianolic Acid A Tablets
NCT04819685Application of KANG FU PEN in Radical Concurrent Radiotherapy and Chemotherapy for Cervical Cancer to Prevent and Treat Radiation-induced Rectal Injury
NCT06411457SHR-A1811 in Combination With Adebrelimab for the Treatment of HER2 Low-expressing Metastatic Breast Cancer
NCT07480863Treatment of Orelabrutinib+Hi-CVP Regimen for Previously Untreated MZL
NCT07689851Chemoradiotherapy and SHR-1701 in Patients With Unresectable Gastric Cancer
NCT04079283Radiomics of Immunotherapeutics Response Evaluation and Prediction
NCT07409766A Phase I Platform Study of Target-Based Screened CAR-Macrophages for the Treatment of Advanced Malignant Tumors
NCT02688023Neoadjuvant Triplet Chemotherapy Regimen in Patients With Resectable Colorectal Cancer
NCT02883374Chidamide for Advanced Cephalic and Cervical Adenocystic Carcinoma: Evaluation of Efficiency and Safety
NCT07013461International Collaborative Study on AJCC/UICC TNM-10 for Nasopharyngeal Cancer
NCT07657403CONNEctome-guided Navigation for Eloquent-area Tumor Surgery Trial
NCT06035250AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy
NCT05783089MSLN-targeted CAR-T Cells in Solid Tumors.
NCT06510543Goal-directed Enteral Nutritional Perioperative Management
NCT04500704Almonertinib Plus Chemotherapy as First-line Treatment in Patients With EGFR Concomitant Non-EGFR Driver Gene Mutant, Locally Advanced or Metastatic NSCLC
NCT04850027MRI-guided Lateral Lymph Node Dissection in Rectal Cancer
NCT06038461An Open, Single-center Clinical Study of Surufatinib Combined With Temozolomide and S-1 in the First-line Treatment of Advanced Neuroendocrine Tumors
NCT05352646NewishT Cell Therapy for HCC With High Risk of Recurrence After Radical Resection
NCT02560441Trial of IPGDP Regimen Chemotherapy in Patients With Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
NCT03291561Perioperative Electroacupuncture After Operation
NCT06612632Immunotherapy Rechallenge in Patients with Solid Tumors in Clinical Trials
NCT06585878A Prospective Registry Study of Stereotactic Ablative Radiotherapy (SABR) for Oligometastatic/Oligometastatic Renal Cell Carcinoma
NCT06649565Prospective Validation and Application of an Artificial Intelligence-based Model for Evaluating the Efficacy of Breast Cancer Patients After Neoadjuvant Therapy
NCT07561463Sacituzumab Tirumotecan for Pancreatic Cancer
NCT06405256Magnetic Resonance Imaging-guided Adaptive Radiotherapy for Large Brain Metastases
NCT02395705Neoadjuvant Chemotherapy Versus Surgery Alone for Esophageal Squamous Cell Carcinoma
NCT07432594Neoadjuvant Aitua (PD-1/CTLA-4 Bispecific) Plus Nab-Paclitaxel and Carboplatin for Advanced High-Grade Serous Ovarian Cancer
NCT02448953Two-field Versus Three-field Lymphadenectomy in Thoracic Esophageal Carcinoma Without Cervical Lymph Node Involvement
NCT06490068Study of LTC004 Combine With Toripalimab in Patient With Solid Tumors Resistant to Immunotherapy
NCT04791176Phase II Study of Concurrent Lenvatinib and Radiotherapy for Advanced HCC
NCT05009017Multi-Centre, Observational Study on Safety of Bevacizumab Biosimilars in Clinical Practice Among Chinese Patients
NCT05749016Neoadjuvant Inetetamab Combined With Pertuzumab and Paclitaxel/Carboplatin for Breast Cancer
NCT06202014Phase II Study of Concurrent Radiotherapy With Envafolimab and Capecitabine in LAPC
NCT02734680IORT Followed by CCRT or SBRT for Locally Advanced Pancreatic Cancer
NCT07040098Optimizing Immunotherapy Combined With Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
NCT04835324Regorafenib Treatment Patterns and Survival Outcomes in Advanced Colorectal Cancer: A Real-world Study
NCT06350370Short-term and Long-term Outcomes of Colorectal Cancer Treated With Natural Orifice Specimen Extraction Surgery : a National Registry-based Study
NCT03579979Sentinel Lymph Node Biopsy in Breast Cancer Surgery Using ICG
NCT07014202Consolidation Radiotherapy vs. Observation in Oligoresidual Advanced Non-Small Cell Lung Cancer After Chemo-Immunotherapy
NCT07476677Darolutamide ± ADT as Neoadjuvant Therapy in High-Risk/Very High-Risk Localized Prostate Cancer
NCT03583619Randomized Trial of Accelerated Partial Breast Irradiation
NCT06185400RC48 Combined With EGFR or HER2 TKI for Locally Advanced or Metastatic NSCLC Patients With HER2 Alterations